1. A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties. Issue 1 (December 2015) Authors: Kastrati, Irida; Litosh, Vladislav; Zhao, Shuangping; Alvarez, Manuel; Thatcher, Gregory; Frasor, Jonna Journal: BMC cancer Issue: Volume 15:Issue 1(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Design, Synthesis, Molecular Modeling, and Biological Evaluation of Novel Amine‐based Histone Deacetylase Inhibitors. (30th November 2017) Authors: Abdelkarim, Hazem; Neelarapu, Raghupathi; Madriaga, Antonett; Vaidya, Aditya S.; Kastrati, Irida; Karumudi, Bhargava; Wang, Yue‐ting; Taha, Taha Y.; Thatcher, Gregory R. J.; Frasor, Jonna; Petukhov, Pavel A. Journal: ChemMedChem Issue: Volume 12:Number 24(2017) Page Start: 2030 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Insights into how phosphorylation of estrogen receptor at serine 305 modulates tamoxifen activity in breast cancer. (1st March 2019) Authors: Kastrati, Irida; Semina, Svetlana; Gordon, Benjamin; Smart, Emily Journal: Molecular and cellular endocrinology Issue: Volume 483(2019) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms. (15th December 2015) Authors: Frasor, Jonna; El-Shennawy, Lamiaa; Stender, Joshua D.; Kastrati, Irida Journal: Molecular and cellular endocrinology Issue: Volume 418:Part 3(2015) Page Start: 235 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗